Middle East & Africa Drug Discovery Informatics Market Size & Outlook
Middle East & Africa drug discovery informatics market, 2018-2030 (US$M)
MEA drug discovery informatics market highlights
- The MEA drug discovery informatics market generated a revenue of USD 158.8 million in 2023.
- The market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, discovery informatics was the largest revenue generating work-flow in 2023.
- Discovery Informatics is the most lucrative work-flow segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 158.8 million |
| Market revenue in 2030 | USD 317.2 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Discovery informatics |
| Fastest growing segment | Discovery Informatics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Discovery Informatics |
| Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.9% of the global drug discovery informatics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,636.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Discovery informatics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa drug discovery informatics market based on discovery informatics covering the revenue growth of each sub-segment from 2018 to 2030.
Conducting clinical trials in Middle East & Africa offers advantages such as patient diversity, cost advantage, infrastructure, and world-class medical facilities. Many regions are initiating to adapt to the global standards and collaborating with other global CROs to mark their presence.
Reasons to subscribe to Middle East & Africa drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa drug discovery informatics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
